-
Published 9/12/2025
Parthasarathy S, Saenjamsai P, Hao H, Ferkul A, Pfannenstiel JJ, Bejan DS, Chen Y, Suder EL, Schwarting N, Aikawa M, Muhlberger E, Hume AJ, Orozco RC, Sullivan CS, Cohen MS, Davido DJ, Fehr AR. PARP14 is an interferon-induced host factor that promotes IFN production and affects the replication of multiple viruses. mBio. 2025 Sep 12; e0229925. PMID: 40937852.
-
Published 7/15/2025
Olejnik J, Meier K, Herrera JN, DeStasio DJ, Deeney DJ, Flores EY, White MR, Hume AJ, Mühlberger E. Harnessing Hazara Virus as a Surrogate for Crimean-Congo Hemorrhagic Fever Virus Enables Inactivation Studies at a Low Biosafety Level. Pathogens. 2025 Jul 15; 14(7). PMID: 40732746.
-
Published 1/1/2025
Suder EL, Hume AJ. Transcription- and Replication-Competent Virus-like Particle Systems for Marburg Virus. Methods Mol Biol. 2025; 2877:141-154. PMID: 39585619.
-
Published 12/3/2024
Schrell L, Fuchs HL, Dickmanns A, Scheibner D, Olejnik J, Hume AJ, Reineking W, Störk T, Müller M, Graaf-Rau A, Diederich S, Finke S, Baumgärtner W, Mühlberger E, Balkema-Buschmann A, Dobbelstein M. Inhibitors of dihydroorotate dehydrogenase synergize with the broad antiviral activity of 4'-fluorouridine. Antiviral Res. 2025 Jan; 233:106046. PMID: 39638153.
-
Published 11/1/2024
Zhao C, Bai Y, Wang W, Amonkar GM, Mou H, Olejnik J, Hume AJ, Mühlberger E, Lukacs NW, Fearns R, Lerou PH, Ai X. Activation of STAT3-mediated ciliated cell survival protects against severe infection by respiratory syncytial virus. J Clin Invest. 2024 Nov 01; 134(21). PMID: 39484716.